WebOct 19, 2024 · Cytocom and Cleveland Biolabs expect the transaction to close during the first quarter of 2024. Cytocom will host a conference call and live audio webcast at 8:00 a.m. EDT on October 28 th to ... WebContact Email [email protected]. Phone Number 1-888-629-4155. Cytocom, Inc. a specialty biotech company, founded by patients, specializing in repurposing of drugs that deploys their patented therapies focused on the activation and rebalancing of the body’s immune system. Stimulating the body’s immune system remains one of the most …
Did you know?
WebImQuest Pharmaceuticals was merged into Cytocom’s existing drug development operations, and ImQuest Biosceinces, the contract research organization (CRO), operates as wholly-owned, revenue-generating … WebSep 28, 2024 · On June 24, 2024, Cytocom completed the acquisition of ImQuest Life Sciences, Inc. and its subsidiaries ("ImQuest") in accordance with the Agreement and Plan of Merger by and among Cytocom and ImQuest dated as of July 17, 2024, and gained control of ImQuest.
WebJul 29, 2024 · Cytocom intends to draw down the first $15 million within 30 days of the closing of the recently completed merger between Cleveland BioLabs and Cytocom. A combination of debt and equity financing ... WebCytocom Subsidiary Inc. Company Profile Fort Collins, CO Competitors, Financials & Contacts - Dun & Bradstreet. Find company research, competitor information, contact …
WebAug 14, 2014 · Cytocom, Inc. is a biotechnology company that will initially focus on developing LDN (Lodonal™) and MENK in the investigation of unmet medical needs in the areas of oncological and inflammatory... WebOct 21, 2024 · Cytocom, Inc. is a leader in immune modulation for the treatment of serious disease is a company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and...
WebIn December 2013, the Company formed a subsidiary, Cytocom Inc. (“Cytocom”), to focus on conducting LDN and MENK clinical trials in the United States. The Company also transferred certain rights to Cytocom, including rights, titles, and interests in or relating to intellectual property, which are further described in the section of ...
WebOct 21, 2024 · Cytocom, Inc. About Cytocom, Inc. Cytocom, Inc. is a leader in immune modulation for the treatment of serious disease is a company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and cancers based on a proprietary platform designed to rebalance the body's immune system and … evans plunge hot springs south dakotaWebOn June 24, 2024, Cytocom completed the acquisition of ImQuest Life Sciences, Inc. and its subsidiaries (“ImQuest”) in accordance with the Agreement and Plan of Merger by … evans police body camerasWebFind company research, competitor information, contact details & financial data for Cytocom Subsidiary Inc. of Fort Collins, CO. Get the latest business insights from Dun & Bradstreet. first citizens bank bellevue waWebOct 21, 2024 · Cytocom, Inc. is a leader in immune modulation for the treatment of serious disease is a company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. evans portsmouth fcWebIn August 2024, Old Cytocom, now a wholly owned subsidiary of the Company, entered into an employment agreement with Mr. Handley, who currently serves as the Chief Executive Officer of Old... evans plus size ladies clothingWebAcquired By: Cytocom Subsidiary Inc. ImQuest BioSciences is a preclinical contract research and development organization (CRO) that provides services to evaluate the … evans plus clothing ukWebJul 6, 2024 · On July 27, 2024, Cytocom, Inc., formerly known as Cleveland BioLabs, Inc. (the “Company” or “Cleveland BioLabs”), High Street Acquisition Corp., a Delaware … evan sports wood ammo box